Myocardial infarction
Therapeutic area
Cardiology
Rare disease
No
- Definition
- Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Myocardial infarction
- Therapeutic area
- Cardiology
- myocardial infarction
- MI
- MI, myocardial infarction
- heart attack
- infarction (MI), myocardial
- myocardial infarct
- myocardial infarction
- myocardial infarction (disease)
- myocardial infarction, (MI)
- All therapeutic areas
- Cardiology
- Severity
- Severe
- MONDO ID
- MONDO:0005068
- Parent condition
- MONDO:0024643
Related records
Broader conditions (6)
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Heart disorder
- Human disease
- Myocardial disorder
Narrower conditions (20)
- Acute anterolateral myocardial infarction
- Acute inferolateral myocardial infarction
- Acute inferoposterior infarction
- Acute myocardial infarction
- Acute subendocardial myocardial infarction
- Anterolateral myocardial infarction
- Anteroseptal myocardial infarction
- Apical myocardial infarction
- Inferior myocardial infarction
- Inferolateral myocardial infarct
- Lateral myocardial infarction
- Myocardial stunning
- Posterior myocardial infarction
- Posteroinferior myocardial infarction
- Posterolateral myocardial infarction
- Septal myocardial infarction
- Silent myocardial infarction
- ST-elevation myocardial infarction
- Strictly posterior acute myocardial infarction
- Subendocardial myocardial infarction
Trials (1,958)
- 10-Years Follow-up of the EXAMINATION Trial
- 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability
- 18F-PBR06/Total Body PET Imaging in Patients With STEMI
- 3D PET Myocardial Blood Flow and Rb82 Infusion Profiles
- 68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction
- 68Ga-NODAGA-RGD PET in Patients With an Occluded Coronary Artery
- 980nm Diode Laser in the Treatment of Periodontal Disease in Cardiac Patients
- A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)
- A Behavioral Economics-Based Telehealth Intervention to Improve Post-MI Medication Adherence
- A CALIBER Study: Risk Factors for Stroke, Heart Failure, and Myocardial Infarction in Atrial Fibrillation
- A Case-control Study of Costa Rican Adults With Myocardial Infarction
- A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study
- A Clinical Trial of IntensiVE Dialysis
- A Clinical Trial to Demonstrate the Efficacy of Cangrelor
- A Cohort of Patients Undergoing Percutaneous Coronary Intervention
- A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
- A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy
- A Digital Flu Intervention for People With Cardiovascular Conditions
- A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction
- A Genomic Approach for Clopidogrel in Caribbean Hispanics
Approved drugs (49)
- Alteplase
- Amlodipine besylate
- Aspirin
- Atenolol
- Atorvastatin calcium
- Candesartan cilexetil
- Cangrelor
- Cangrelor tetrasodium
- Captopril
- Carvedilol
- Carvedilol phosphate
- Clopidogrel besilate
- Clopidogrel bisulfate
- Clopidogrel hydrobromide
- Clopidogrel hydrochloride
- Dopamine hydrochloride
- Doxazosin mesylate
- Enoxaparin sodium
- Eplerenone
- Eptifibatide
Drugs in development (101)
- Abciximab Phase 3
- Acetylcysteine Phase 3
- Adenosine Phase 3
- Aliskiren Phase 3
- Amediplase Phase 3
- Amiodarone Phase 3
- Amlodipine Phase 3
- Anfibatide Phase 2
- Ascorbic acid Phase 2
- Aspirin trelamine Phase 2
- Atorvastatin Phase 2
- Azithromycin Phase 3
- Balixafortide Phase 2
- Beta carotene Phase 2
- Bivalirudin Phase 3
- Calcifediol Phase 3
- Caldaret monohydrate Phase 2
- Chlorthalidone Phase 3
- Cholestyramine Phase 3
- Clofibrate Phase 3
Other linked drugs (16)
- Annexin A5
- Arginine
- Caffeine
- Everolimus
- Fluvastatin
- Gadoversetamide
- GLP-1
- Imciromab
- Lanoteplase
- Nateplase
- Rimeporide
- Sodium nitrite
- Tocilizumab
- Urokinase
- Vonoprazan fumarate
- Vorapaxar